This invention relates to pharmaceutical combinations suitable for treating the lower urinary tract symptoms associated with benign prostatic hyperplasia in men, which combinations contain- an alpha-adrenoceptor antagonist and a muscarinic antagonist. The combinations of the invention are particularly suitable for treating moderate or severe lower urinary tract symptoms.